Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2000
05/11/2000CA2348392A1 Method for producing luteolin and luteolin derivatives
05/11/2000CA2348267A1 Novel inhibitors of impdh enzyme
05/11/2000CA2348234A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
05/11/2000CA2347855A1 Use of a nicotine receptor agonist in the treatment of obsessive compulsive disorder
05/11/2000CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2345337A1 Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0999219A2 Novel heparin binding peptides
05/10/2000EP0998945A1 Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
05/10/2000EP0998931A1 Remedies for dry eye
05/10/2000EP0998924A1 Antitumor agents
05/10/2000EP0998906A2 Shampoo composition
05/10/2000EP0998582A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
05/10/2000EP0998573A2 Fusion proteins with an immunoglobulin hinge region linker
05/10/2000EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
05/10/2000EP0998568A1 Mutant having uracil phosphoribosyl transferase activity
05/10/2000EP0998561A1 Trail receptor
05/10/2000EP0998558A1 Wa545 compositions
05/10/2000EP0998556A2 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
05/10/2000EP0998494A1 Pompilid wasp-derived neuropeptides
05/10/2000EP0998477A1 Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents
05/10/2000EP0998475A1 Novel compounds
05/10/2000EP0998474A1 Piperazine derivatives
05/10/2000EP0998473A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
05/10/2000EP0998471A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
05/10/2000EP0998460A1 Novel tetrazole derivatives
05/10/2000EP0998459A2 Pyridine derivatives
05/10/2000EP0998454A2 Metalloproteinase inhibitors
05/10/2000EP0998300A1 Methods and compositions for modulating responsiveness to corticosteroids
05/10/2000EP0998299A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF
05/10/2000EP0998298A2 Method of an increasing the antigen presenting ability of monocytes
05/10/2000EP0998294A1 Ganglioside gm3 induced apoptosis of neural cells
05/10/2000EP0998293A1 Cytokine related treatments of disease
05/10/2000EP0998292A2 Method for inhibiting bone resorption
05/10/2000EP0998291A1 Treatment of diabetes with thiazolidinedione and sulphonylurea
05/10/2000EP0998289A1 Composition and method for supplementing testosterone in women with symptoms of testosterone deficiency
05/10/2000EP0998285A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
05/10/2000EP0998283A1 Calcilytic compounds
05/10/2000EP0998282A1 Sulfonamides as cell adhesion inhibitors
05/10/2000EP0998278A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
05/10/2000EP0998275A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-kappaB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
05/10/2000EP0998274A2 Microdose therapy of vascular conditions by no donors
05/10/2000EP0998272A1 Pharmaceutical composition for combination of piperidinoalkanol-decongestant
05/10/2000EP0998251A2 Compositions and methods for inhibiting photoaging of skin
05/10/2000EP0800503B1 Novel trienoic retinoid compounds and methods
05/10/2000EP0763031B1 Piperazine derivatives as 5ht1a antagonists
05/10/2000EP0762879B1 Stereochemical wortmannin derivatives
05/10/2000EP0743939B1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
05/10/2000EP0736004B1 (2,4-disulfophenyl) n-tertiary butyl nitrone, its salts, and their use as pharmaceutical radical trapping agents
05/10/2000EP0671922B1 Fluidized intestinal submucosa and its use as an injectable tissue graft
05/10/2000CN1252811A Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics
05/10/2000CN1252800A Farnesyltransferase inhibiting quinazolinones
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252798A Indazole amide compounds as 5-serotoninergic agents
05/10/2000CN1252793A 4-aminoalkoxy-1H-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor D2 agonists
05/10/2000CN1252730A Lyme combination compositions and uses
05/10/2000CN1252729A Production process for intravenous immune serum globulin and resultant product
05/10/2000CN1252727A Method and composition for treating sleep apnea
05/10/2000CN1252726A Methods for treating vascular disorders
05/10/2000CN1252716A Inhibitor of leaderless protein export
05/10/2000CN1252441A Recombined-adenovirus accompanying virus production method and application
05/10/2000CN1052231C 2-oxo-5-oxazolidone methyl compound their preparing method and medicinal composition containing them
05/10/2000CN1052227C Oxazolidone used as adhesive receptor antagenists, its preparing method and medicinal composition containing them
05/10/2000CN1052218C Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromans
05/09/2000US6060589 Agouti-related proteins
05/09/2000US6060506 Benzopyran derivatives as melatonergic agents
05/09/2000US6060499 Concurrently administering mixture of long-acting non-steroidal antiinflammatory drug (la-nsaid) with 5ht agonist to reduce relapse
05/09/2000US6060492 Side effect reduction
05/09/2000US6060487 Indanol compounds
05/09/2000US6060482 Serotonin inhibitors
05/09/2000US6060479 Quinazoline-4-one AMPA antagonists
05/09/2000US6060475 Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof
05/09/2000US6060469 Spiro-piperidine derivatives and their use as tachykinin antagonists
05/09/2000US6060467 Graft survival prolongation with porphyrins
05/09/2000US6060460 Use of betaglycan to reduce scarring
05/09/2000US6060458 Oligodeoxyribonucleotides comprising O6 -benzylguanine and their use
05/09/2000US6060446 Protein and carnosine, glutathione, and/or cyclo-histidine-proline
05/09/2000US6060294 Alanyl tRNA synthetase from Staphylococcus aureus
05/09/2000US6060273 Multicistronic expression units and their use
05/09/2000US6060250 Human transferases
05/09/2000US6060061 Method for preventing or treating disorders involving an inflammatory process
05/09/2000US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety
05/09/2000CA2153584C Cytokine restraining agents
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/09/2000CA2065285C Antimalarial compositions
05/09/2000CA1340987C Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime, processof preparation, their use as medicine and compositions containing same
05/04/2000WO2000024922A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024885A2 p53 MORPHOLINO-BASED ANTISENSE
05/04/2000WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents
05/04/2000WO2000024779A1 Lysine-rich statherin protein
05/04/2000WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000WO2000024763A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/04/2000WO2000024755A1 Ovary-specific genes and proteins
05/04/2000WO2000024745A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION
05/04/2000WO2000024742A1 Pyrazolopyridine as adenosine antagonists
05/04/2000WO2000024741A2 Dihydropyridine compounds and their use as potassium channel openers
1 ... 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 ... 1564